Cargando…
Clozapine in the Time of COVID-19
Clozapine is the most effective antipsychotic for treatment resistant schizophrenia but adverse reactions to clozapine include neutropenia. The current COVID-19 pandemic may raise specific concerns for clinicians prescribing clozapine for patients who need it. We report on two actively psychotic pat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean College of Neuropsychopharmacology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383003/ https://www.ncbi.nlm.nih.gov/pubmed/32702224 http://dx.doi.org/10.9758/cpn.2020.18.3.450 |